Phoundry Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Phoundry Pharmaceuticals Ownership

Who owns Phoundry Pharmaceuticals?

Phoundry Pharmaceuticals is owned by Intarcia Therapeutics. It was acquired on September 24, 2015.

Phoundry Pharmaceuticals Business Overview

Where is Phoundry Pharmaceuticals headquartered?

Phoundry Pharmaceuticals is headquartered in Research Triangle Park, North Carolina.

What sector is Phoundry Pharmaceuticals in?

Phoundry Pharmaceuticals is a life science company.

When was Phoundry Pharmaceuticals founded?

Phoundry Pharmaceuticals was founded in 2015.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Phoundry Pharmaceuticals, Inc.

6 Davis Drive,
Research Triangle Park, North Carolina 27709
United States,
(919) 281-2441

Phoundry Pharmaceuticals, Inc. is a bio pharmaceutical company developing therapies to enhance treatment outcomes by optimizing and improving the efficacy, continuous administration and tolerability of drug therapies.

 Subscribe to unlock this and 203,291
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.6K Private Equity Firms
  • 195K M&A Transactions
  • 199K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.